Home/Filings/4/0002064884-25-000003
4//SEC Filing

Alibhai Imran Nizamudin 4

Accession 0002064884-25-000003

CIK 0001346830other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 5:00 PM ET

Size

5.8 KB

Accession

0002064884-25-000003

Insider Transaction Report

Form 4
Period: 2025-12-16
Alibhai Imran Nizamudin
DirectorChief Executive Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-12-16+47,50047,500 total
    Exercise: $4.20Exp: 2035-12-16Common Stock (47,500 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option shall vest on December 16, 2026, and the balance of the shares subject to the option shall vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continuous service through each applicable vesting date.

Issuer

Tvardi Therapeutics, Inc.

CIK 0001346830

Entity typeother

Related Parties

1
  • filerCIK 0002064884

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 5:00 PM ET
Size
5.8 KB